Alpha Cognition Prices $35 Million Public Offering of Shares
October 1, 2025
Offering was led by an initial investment from a premier healthcare-dedicated investor alongside multiple large existing shareholders Alpha Cognition Inc., a commercial-stage biopharmaceutical company dedicated